Prevalence and treatment conditions for hypertension and dyslipidaemia complicated with systemic lupus erythematosus: A multi-centre cross-sectional study.
Saito MayuNobuyuki YajimaRyo YanaiYumi TsubokuraKunihiro IchinoseRyusuke YoshimiShigeru OhnoKen-Ei SadaPublished in: Lupus (2021)
About half of the patients had hypertension or dyslipidaemia, and a considerable number of cases were poorly controlled despite medication. Our data suggest that physicians should treat SLE activity as well as its complications, especially the common risk factors for atherosclerosis.
Keyphrases
- systemic lupus erythematosus
- blood pressure
- end stage renal disease
- risk factors
- disease activity
- chronic kidney disease
- newly diagnosed
- ejection fraction
- primary care
- cardiovascular disease
- emergency department
- electronic health record
- machine learning
- patient reported outcomes
- rheumatoid arthritis
- artificial intelligence
- deep learning
- replacement therapy